Cyproheptadine 4 mg Tablets — Generic For Periactin — Strides

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Cyproheptadine hydrochloride tablets are a prescription medicine available as 4 mg oral tablets. The label describes cyproheptadine as an antihistaminic and antiserotonergic agent with anticholinergic and sedative effects.

These tablets are indicated for certain allergy-related conditions, including perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions such as urticaria and angioedema, cold urticaria, dermatographism, and allergic reactions to blood or plasma. The label also states they may be used as adjunctive therapy for anaphylactic reactions after the acute manifestations have been controlled.

The label warns that antihistamines may diminish mental alertness and may cause dizziness, sedation, or hypotension. It also notes that overdosage can be serious, especially in infants and young children. Safety and effectiveness in children under 2 years of age have not been established.

Storage Information

Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

Key Counseling Points

• This medicine is a prescription antihistamine and antiserotonergic agent.
• It is used for certain allergy-related conditions such as allergic rhinitis, allergic conjunctivitis, urticaria, and angioedema.
• The label states it may be used as adjunctive therapy for anaphylactic reactions after the acute manifestations have been controlled.
• Cyproheptadine may cause drowsiness, dizziness, or reduced mental alertness.
• Use caution with activities that require alertness and motor coordination, such as driving or operating machinery.
• Alcohol and other CNS depressants may have additive effects with this medicine.
• MAO inhibitors may prolong and intensify the anticholinergic effects of antihistamines.
• The label warns that overdosage can cause central nervous system effects and atropine-like symptoms, especially in pediatric patients.
• Safety and effectiveness in pediatric patients below age 2 have not been established.
• The product contains 4 mg of cyproheptadine hydrochloride per tablet.

Helpful Patient Education

Cyproheptadine hydrochloride tablets USP are prescription 4 mg tablets described on the DailyMed label as an antihistaminic and antiserotonergic agent. The label lists uses for several allergy-related conditions, including allergic rhinitis, allergic conjunctivitis, urticaria, angioedema, and other hypersensitivity reactions.

Educational information for cyproheptadine HCl tablets should also note the label warnings about sedation, dizziness, and decreased alertness, as well as interactions with alcohol and other CNS depressants. This product is supplied as white to off-white, round, scored tablets debossed "C4".

Medication Summary last generated: 2026-07-17 03:00:27